News

Use of SKYCellflu Quadrivalent, Vaxigrip Tetra Influenza Vaccines Can Be Continued – Health DG

KUALA LUMPUR,  Nov 3  — Two influenza vaccine products, Vaxigrip Tetra and SKYCellflu Quadrivalent, which were temporarily discontinued, can now be used, said Health director-general Tan Sri Dr Noor Hisham Abdullah.

He said the Health Ministry, through the National Pharmaceutical Regulatory Agency (NPRA), has conducted a detailed risk assessment for the two vaccine brands based on information received from the Korean Disease Control and Prevention Agency (KDCA), local and global safety reports and other international regulatory bodies.

“As of Oct 31, the KDCA confirmed that the probability of linking the influenza vaccine as the cause of death, as reported (previously), is very low.

“The investigation report for 72 cases out of 83 death cases (11 cases still under investigation) shows that, the cause of death is due to the existing illness suffered by the individuals concerned  or other causes that have nothing to do with the given influenza vaccine,” he said on Facebook.

Last Oct 28, the Health Ministry advised medical practitioners to temporarily stop the use of the two influenza vaccine following reports of deaths associated with the products in South Korea.

Dr Noor Hisham said the KDCA also confirmed that there were no specific brands, manufacturers or vaccine cluster numbers that could be linked to the deaths.

The Health Ministry, he said, had also evaluated the quality of the products and reviewed local and global reports on the adverse event following immunisation  (AEFI)  covering the safety profile of all influenza vaccines, including both the vaccines.

He said a total of 1.5 million doses of influenza vaccine had been brought into Malaysia until October this year with the results of their evaluations, including the two brands of vaccines, to be in compliance with the prescribed quality standards.

“Further checks  also found no case of death was reported following the administration of any influenza vaccine in Malaysia. The adverse effects that were reported are common adverse effects and have been documented,” he added.

Source: BERNAMA

Adib Mohd

Recent Posts

Designing for Wellness: Cosentino’s “Voices of Design” Explores Wellness and Spaces

Kuala Lumpur, 23 June 2026 – Cosentino, in partnership with Matthew Lim, Founder and Principal… Read More

15 hours ago

The First-Ever “Walk With Hope for Dementia” Raises RM119,579 in Support of Alzheimer’s and Dementia Awareness

Johor Bahru, 29 June 2026 — The first-ever “Walk With Hope for Dementia” jointly organised… Read More

21 hours ago

Resorts World Genting Unveils Genting Guest Xperience Centre, a New Immersive Showcase of Legacy and Innovation

Genting Highlands, 29 June 2026 – The Genting Guest Xperience Centre (GGXC) is Resorts World… Read More

21 hours ago

Merz Aesthetics – Ultherapy Mask Approval Malaysia

Kuala Lumpur, 26 June 2026: Merz Aesthetics, the world’s largest dedicated medical aesthetics company, announced… Read More

22 hours ago

Hong Kong Turns Up the Summer Fun with Festivals, Football Fever and Exclusive Travel Rewards

Kuala Lumpur, 29 June 2026 - Looking for a summer getaway that combines world-class entertainment,… Read More

22 hours ago

Southeast Asia’s 1st Tomica Factory Debuts At Tomica Brand Store Kuala Lumpur

Kuala Lumpur, 27 June 2026 — Iconic diecast miniature car brand TOMICA has officially launched… Read More

23 hours ago

This website uses cookies.